EZH2 mutations and impact on clinical outcome: an analysis in 1,604 patients with newly diagnosed acute myeloid leukemia

Stasik S, Middeke JM, Kramer M, Roellig C, Kraemer A, Scholl S, Hochhaus A, Crysandt M, Bruemmendorf TH, Naumann R, Steffen B, Kunzmann V, Einsele H, Schaich M, Burchert A, Neubauer A, Schaefer-Eckart K, Schliemann C, Krause S, Herbst R, Haenel M, Frickhofen N, Noppeney R, Kaiser U, Baldus CD, Kaufmann M, Racil Z, Platzbecker U, Berdel WE, Mayer J, Serve H, Mueller-Tidow C, Ehninger G, Bornhaeuser M, Schetelig J, Thiede C (2020)


Publication Type: Journal article

Publication year: 2020

Journal

Book Volume: 105

Pages Range: e228-e231

Journal Issue: 5

DOI: 10.3324/haematol.2019.222323

Authors with CRIS profile

Involved external institutions

How to cite

APA:

Stasik, S., Middeke, J.M., Kramer, M., Roellig, C., Kraemer, A., Scholl, S.,... Thiede, C. (2020). EZH2 mutations and impact on clinical outcome: an analysis in 1,604 patients with newly diagnosed acute myeloid leukemia. Haematologica, 105(5), e228-e231. https://doi.org/10.3324/haematol.2019.222323

MLA:

Stasik, Sebastian, et al. "EZH2 mutations and impact on clinical outcome: an analysis in 1,604 patients with newly diagnosed acute myeloid leukemia." Haematologica 105.5 (2020): e228-e231.

BibTeX: Download